Wells Fargo’s Tevogen Inc TVGN Stock Holding History

Wells Fargo’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79	Sell	14 -297	-95%	-$2.37K	﹤0.01%	6669
2026 Q1	$1.41K	Sell	311 -599	-66%	-$7.34K	﹤0.01%	6296
2025 Q4	$15.1K	Buy	910 +503	+124%	+$13.1K	﹤0.01%	5865
2025 Q3	$16K	Buy	407 +83	+26%	+$4.08K	﹤0.01%	5848
2025 Q2	$20.3K	Buy	324 +77	+31%	+$4.39K	﹤0.01%	5790
2025 Q1	$13.3K	Buy	247 +11	+5%	+$724	﹤0.01%	5821
2024 Q4	$12.1K	Buy	236 +68	+40%	+$4.43K	﹤0.01%	5895
2024 Q3	$3.09K	Buy	168 +5	+3%	+$146	﹤0.01%	6005
2024 Q2	$5.89K	Buy	+163	New	+$10.6K	﹤0.01%	5845

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Wells Fargo's TVGN Position: Q2 2026 in Review

Wells Fargo reduced its Tevogen Inc (TVGN) stake by 95% in Q2 2026, selling an estimated $2.37K and leaving 14 shares worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #6669.

Wells Fargo first reported a position in TVGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $20.3K in Q2 2025. 31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

Wells Fargo held 14 shares of Tevogen Inc worth $79 as of Q2 2026.
Wells Fargo sold 297 Tevogen Inc shares in Q2 2026, an estimated $2.37K.
Tevogen Inc made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6669 holding.
Wells Fargo first reported a position in Tevogen Inc in Q2 2024 and has held it in 9 quarters since.
Wells Fargo's Tevogen Inc position peaked at $20.3K in Q2 2025.
31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.